Clotrimazole

Antifungal Azole antifungal (imidazole derivative)

Dosage & Administration Guidelines

Species Route Dose Frequency Duration & Clinical Notes
Dog Topical (cream, lotion, spray) Apply to affected area 2-3 times daily Duration: 2-4 weeks, continue for 1-2 weeks after clinical resolution
Notes: For otitis externa: instill 2-4 drops (or 1-2 mL) into ear canal twice daily for 7-14 days.
Cat Topical (cream, lotion, spray) Apply to affected area 2-3 times daily Duration: 2-4 weeks, continue for 1-2 weeks after clinical resolution
Notes: For otitis externa: instill 2-4 drops (or 1-2 mL) into ear canal twice daily for 7-14 days.
Horse Topical (cream, lotion, spray) Apply to affected area 2-3 times daily Duration: 2-4 weeks
Notes: For fungal keratitis: 1% ophthalmic solution/ointment applied 4-6 times daily.
Cattle Topical (spray, cream) Apply to affected area 2-3 times daily Duration: 2-4 weeks
Notes: For ringworm: clip hair around lesion and apply; avoid contamination of milk and meat.
Small Ruminants Topical (cream, spray) Apply to affected area 2-3 times daily Duration: 2-4 weeks
Notes: For ringworm: clip hair and apply; observe withdrawal times.
Rabbit Topical (cream, solution) Apply to affected area 2-3 times daily Duration: 2-4 weeks
Notes: For otitis: instill 2-3 drops into ear canal twice daily for 7-14 days.
Bird/Poultry Topical (cream, solution) Apply to affected area 2-3 times daily Duration: 2-4 weeks
Notes: For oral candidiasis: apply to oral mucosa; systemic therapy may be preferred.
Exotic/Other Topical (cream, solution) Apply to affected area 2-3 times daily Duration: 2-4 weeks
Notes: For reptiles: apply to affected skin; ensure proper environmental conditions.

Clinical Indications & Species Uses

General Indications
  • Topical treatment of superficial fungal infections caused by susceptible organisms (dermatophytes, Malassezia, Candida)
Dog (Canine)
  • Topical treatment of dermatophytosis (ringworm)
  • Malassezia dermatitis
  • Cutaneous candidiasis
  • Otitis externa (fungal or mixed)
  • Topical treatment of skin fold dermatitis with fungal component
Cat (Feline)
  • Topical treatment of dermatophytosis (ringworm)
  • Malassezia dermatitis
  • Cutaneous candidiasis
  • Otitis externa (fungal or mixed)
Horse (Equine)
  • Topical treatment of dermatophytosis (ringworm)
  • Treatment of fungal keratitis (ophthalmic preparation)
  • Treatment of thrush (if fungal component)
Cattle (Bovine)
  • Topical treatment of dermatophytosis (ringworm)
  • Treatment of bovine interdigital dermatitis (if fungal component)
Small Ruminants (Sheep / Goat)
  • Topical treatment of dermatophytosis (ringworm)
Rabbit & Small Mammals
  • Topical treatment of dermatophytosis (ringworm)
  • Treatment of Malassezia otitis externa
Avian & Poultry
  • Topical treatment of dermatophytosis (ringworm)
  • Treatment of candidiasis (oral or topical, though systemic therapy may be preferred)
Exotic & Other Species
  • Topical treatment of dermatophytosis in reptiles (e.g., snakes, lizards)
  • Treatment of fungal dermatitis in small mammals (e.g., guinea pigs, hamsters)

Pharmacology & Mechanism of Action

Drug Class: Antifungal | Pharmacological Group: Azole antifungal (imidazole derivative)

Mechanism of Action: Clotrimazole inhibits fungal cytochrome P450 14α-demethylase, which is essential for the conversion of lanosterol to ergosterol, a key component of the fungal cell membrane. This leads to increased membrane permeability, leakage of cellular contents, and ultimately fungal cell death. It is primarily fungistatic at therapeutic concentrations but may be fungicidal at higher concentrations.

Pharmacodynamics: Clotrimazole exhibits a broad spectrum of antifungal activity against dermatophytes (e.g., Microsporum, Trichophyton), yeasts (e.g., Candida, Malassezia), and some other fungi. It is also active against some Gram-positive bacteria. Its activity is pH-dependent, with optimal activity in slightly acidic environments. Resistance is uncommon but may develop with prolonged use.

⚡ Pharmacokinetics Summary

Absorption: When applied topically, systemic absorption is minimal (less than 5% in most species). Oral absorption is poor and erratic; therefore, oral use is limited. In the gastrointestinal tract, it is poorly absorbed and may cause local effects.
Distribution: After topical application, it penetrates the stratum corneum and accumulates in the skin, hair, and nails. Systemic distribution is negligible after topical use. If absorbed, it is widely distributed and crosses the placenta.
Metabolism: Clotrimazole is extensively metabolized in the liver to inactive metabolites. It inhibits its own metabolism with repeated dosing.
Excretion: Metabolites are excreted primarily in the feces (via bile) and to a lesser extent in urine. After topical application, the unabsorbed drug is shed with skin debris.
Half-Life: Systemic half-life is short (approximately 2-4 hours in dogs and cats) but is not clinically relevant for topical therapy.
Bioavailability: Oral bioavailability is very low (<5%) due to poor absorption and extensive first-pass metabolism. Topical bioavailability is not applicable as the drug acts locally.
Protein Binding: Approximately 90% bound to plasma proteins (if systemically absorbed).

Available Formulations & Strengths

Topical Cream 1% (Topical)
Topical Lotion 1% (Topical)
Topical Solution/Spray 1% (Topical)
Otic Solution/Suspension 1% (Otic)
Ophthalmic Solution/Ointment 1% (Ophthalmic)
Oral Troche/Lozenges (human) 10 mg (Oral (rarely used in veterinary medicine))

Contraindications & Clinical Warnings

Contraindications:
  • Hypersensitivity to clotrimazole or any component of the formulation
  • Do not use in eyes (unless specifically formulated for ophthalmic use)
  • Do not use systemically in animals with hepatic impairment (if oral use is considered)
Warnings & Clinical Precautions:
  • For topical use only; avoid contact with eyes (unless ophthalmic preparation).
  • Do not use in animals with perforated tympanic membrane (for otic preparations).
  • Use with caution in pregnant or lactating animals (safety not fully established).
  • In food animals, observe withdrawal times; avoid contamination of milk and meat.
  • If no improvement within 2 weeks, re-evaluate diagnosis.
  • Avoid use of occlusive dressings unless directed by veterinarian.
  • Keep out of reach of children and animals.

Adverse Effects & Reactions

Common:

  • Local irritation
  • Redness
  • Burning or stinging sensation at application site

Serious / Severe:

  • Allergic contact dermatitis
  • Anaphylaxis (rare)

Rare:

  • Systemic toxicity after topical application (very unlikely due to low absorption)
  • Hepatotoxicity (if oral use)

Key Drug Interactions

Interacting Drug / Class Clinical Effect & Mechanism Severity
Amphotericin B Clotrimazole may antagonize the antifungal effect of amphotericin B (azole inhibits ergosterol synthesis, reducing target for amphotericin). Moderate
Corticosteroids (topical) May mask signs of fungal infection; combination may be used for anti-inflammatory effect but should be used cautiously. Mild
Other azole antifungals (e.g., ketoconazole, itraconazole) Additive antifungal effect; may increase risk of hepatotoxicity if systemic. Moderate
CYP450 inhibitors/inducers Clotrimazole inhibits CYP450 enzymes; may increase levels of drugs metabolized by these enzymes (e.g., cyclosporine, tacrolimus) if systemic absorption occurs. Moderate

Overdose & Toxicity Management

Signs of Toxicity:

  • Topical overdose: severe local irritation, erythema, blistering
  • Oral overdose: vomiting, diarrhea, anorexia, hepatotoxicity (rare)

Emergency Treatment Protocol: For topical overdose, remove excess drug and treat symptomatically. For oral overdose, induce emesis if recent and perform supportive care (fluids, monitoring liver enzymes). There is no specific antidote.

Food Animal Withdrawal Times

🥩 Meat: 0 days🥛 Milk: 0 days🥚 Eggs: 0 days

Clotrimazole is not systemically absorbed after topical application, so withdrawal times are generally zero. However, for food animals, follow label instructions and local regulations; some countries may require a withdrawal period for extralabel use.

Storage, Handling & Regulatory Information

Storage Temperature: Store at room temperature (15-30°C / 59-86°F)

Handling & Special Conditions: Keep container tightly closed. Do not freeze. Protect from excessive heat.

Dispensing Status: Over-The-Counter (OTC)

Approval Status: Approved for human use; not specifically approved for veterinary use, but may be used extralabel in animals.

Extra-Label (Off-Label) Use: In the US, clotrimazole is available over-the-counter for human use, but veterinary use may be extralabel. Under AMDUCA, extralabel use of approved animal and human drugs is permitted by or on the order of a veterinarian within a valid VCPR, provided withdrawal times are observed for food animals.

Clinical Pearls & Practice Notes

💡 Clinical Insights: Clotrimazole is a safe and effective topical antifungal for superficial mycoses in various species. It is particularly useful for dermatophytosis and Malassezia dermatitis. For systemic or deep infections, other azoles (e.g., itraconazole) are preferred. In otitis externa, ensure the tympanic membrane is intact before using otic preparations. For food animals, topical use is generally safe with no withdrawal times, but always check local regulations. Combination therapy with other antifungals may be considered in refractory cases. Client education should emphasize the importance of completing the full course of treatment and environmental decontamination to prevent reinfection.

References & Literature

  • 📚 Plumb's Veterinary Drug Handbook
  • 📚 Papich Veterinary Pharmacology and Therapeutics
  • 📚 Compendium of Veterinary Products (CVP)